Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

被引：0

作者：

Scanlan, Claire ^{[1
]}

Pattnaik, Priyabrata ^{[2
]}

Waghmare, Ruta ^{[1
]}

Gousseinov, Elina ^{[1
]}

Kozlov, Mikhail ^{[1
]}

Hammons, Aaron ^{[1
]}

Bei, Ling ^{[1
]}

Benchek, Youssef ^{[1
]}

Pirani, Karim ^{[1
]}

机构：

[1] MilliporeSigma, Billerica, MA 01821 USA

[2] Merck Pte Ltd, Biomfg Sci & Training Ctr, Singapore, Singapore

来源：

BIOPHARM INTERNATIONAL | 2016年 / 29卷 / 07期

关键词：

MESSENGER-RNA; PLASMID DNA; CHROMATOGRAPHY; PURIFICATION;

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

In 2014, the monoclonal antibodies market had the highest growth rate (19%) for the number of new molecules in the pipeline. DNA and RNA therapeutics were not far behind, achieving 12% year-over-year growth. Industry analytics data suggest that the RNA-based therapeutics market will reach $1.2 billion by 2020.

引用

页码：30 / +

页数：8

共 30 条

[1] The Sm domain is an ancient RNA-binding motif with oligo(U) specificity [J].